NR4A1 and breast cancer: For the former group of breast cancers, anticancer drugs including P450 inhibitors or steroid receptor-targeting molecules were included within the structure of the complexes whereas for the latter group, due to the lack of expression of hormone receptors, anticancer drugs with other modes of action (such as nonsteroidal anti-inflammatory drugs) were used as ligands.